NSE ScannerComparison · NSE · data 2026-10-31
Lincoln Pharmaceuticals Ltd vs Themis Medicare Limited
In plain words
Size: Lincoln Pharmaceuticals Ltd is about 1.1 times the market value of Themis Medicare Limited.
Valuation (P/E): Themis Medicare Limited 21.9 vs Lincoln Pharmaceuticals Ltd 10.4.
Return on equity: Lincoln Pharmaceuticals Ltd 12.3% vs Themis Medicare Limited 0.3%.
Profit growth over 3 years: Lincoln Pharmaceuticals Ltd 6.4% a year vs Themis Medicare Limited -72.8% a year.
Debt to equity: Themis Medicare Limited 0.25 vs Lincoln Pharmaceuticals Ltd 0.01.
Differences in the numbers, not a recommendation of either stock.
Side by side
| LINCOLN | THEMISMED | |
|---|---|---|
| Price | ₹499.3 | ₹94.83 |
| Market cap | ₹1,005 cr | ₹875 cr |
| P/E | 10.4 | 21.9 |
| P/B | — | — |
| ROE | 12.3% | 0.3% |
| ROCE | 10.9% | -2.3% |
| Debt / equity | 0.01 | 0.25 |
| Operating margin | 12.4% | -15.8% |
| Dividend yield | 0.36% | 0.53% |
| Sales growth, 3 years (yearly) | 9.4% | -1.2% |
| Profit growth, 3 years (yearly) | 6.4% | -72.8% |
| 1-year return | -5.8% | -24.0% |
| Revenue, last 12 months | ₹694 cr | ₹332 cr |
| Net profit, last 12 months | ₹96 cr | ₹40 cr |
| Latest quarter | — | Mar 2026 |
| Quarter net profit | — | ₹9 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 49.78% | 67.15% |
| Health check | Strong (6.6/10) | Weak (3.9/10) |
Common questions
Which has a higher P/E, Lincoln Pharmaceuticals Ltd or Themis Medicare Limited?
Themis Medicare Limited trades at the higher P/E (21.9 against 10.4). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Lincoln Pharmaceuticals Ltd (12.3% against 0.3%).
Which carries more debt?
Themis Medicare Limited has the higher debt-to-equity ratio (0.25 against 0.01).